Related Experiment Video

Updated: Jun 3, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Ménière's disease: a challenging and relentless disorder

Maroun T Semaan1, Cliff A Megerian

  • 1Division of Otology and Neurotology, Department of Otolaryngology and Head & Neck Surgery, University Hospitals Case Medical Center, Louis Stokes Veteran's Affair Medical Center, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Lakeside 4528, Cleveland, OH 44106, USA. maroun.semaan@UHHospitals.org

Otolaryngologic Clinics of North America
|April 9, 2011
PubMed

Insights

Ménière's disease (MD) management remains challenging, particularly for progressive hearing loss. Recent research suggests neurotoxicity plays a role in cochleovestibular decline, prompting a review of current treatment algorithms.

Area of Science:

  • Otolaryngology
  • Neurology
  • Internal Medicine

Background:

  • Ménière's disease (MD) presents with episodic vertigo, fluctuating hearing loss, and tinnitus.
  • Endolymphatic hydrops is a characteristic finding in postmortem examinations of MD patients.
  • MD poses significant diagnostic and therapeutic challenges, with a wide range of patient symptom severity.

Observation:

  • Current MD management focuses on acute symptoms but inadequately addresses progressive cochlear dysfunction.
  • Patient outcomes vary significantly, from minimal symptoms to severe disability.
  • Emerging research indicates a potential role for neurotoxicity in the pathogenesis of cochleovestibular deterioration in MD.

Findings:

  • This article reviews the current understanding of MD pathogenesis, emphasizing neurotoxicity.
  • A case study of an MD patient is presented to illustrate clinical challenges.
  • An updated management algorithm for Ménière's disease is proposed.

Implications:

  • Improved understanding of MD pathogenesis may lead to novel therapeutic targets.
  • A structured management algorithm can aid clinicians in treating complex MD cases.
  • Addressing neurotoxicity could offer new hope for preserving cochlear function in MD patients.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are: